RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Bowling Green, KY · Louisville, KY · Owensboro, KY · +119 more sites
Psoriasis clinical trials in Bowling Green, KY
3 recruiting psoriasis studies with a site in Bowling Green, KY.
RecruitingPhase 2NCT07449702
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Sponsor: Oruka Therapeutics, Inc.
Bowling Green, KY · +21 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Bowling Green, KY · +38 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.